Close

Search

Search Menu
Photonics Media Photonics Buyers' Guide Photonics EDU Photonics Spectra BioPhotonics EuroPhotonics Industrial Photonics Photonics Showcase Photonics ProdSpec Photonics Handbook
More News
SPECIAL ANNOUNCEMENT
2016 Photonics Buyers' Guide Clearance! – Use Coupon Code FC16 to save 60%!
share
Email Facebook Twitter Google+ LinkedIn Comments

IOPtima Ltd.

BioPhotonics
Aug 2008
IOPtima Ltd. of Ramat Gan, Israel, has completed the three-month follow-up period for its initial human clinical study using the OT134 device. The laser-based therapy enables eye surgeons to operate and reduce internal eye pressure without penetrating the ocular membrane. So far, the results suggest that the laser filtration system may be a viable alternative to current glaucoma therapies.


Comments
Terms & Conditions Privacy Policy About Us Contact Us
back to top

Facebook Twitter Instagram LinkedIn YouTube RSS
©2016 Photonics Media
x Subscribe to BioPhotonics magazine - FREE!